Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
This is the first study that aimed to determine antigen levels in plasma and genotypes of PAI-2 in pregnant and non-pregnant homozygous sickle cell anemia (SCA) patients.